El trading conlleva riesgos
Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
El trading conlleva riesgos
Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
Español (Latinoamérica)
LeMaitre Vascular Inc
Cerrado
SectorSalud
106.75 1.26
Resumen
Variación precio
24h
Mínimo
101.8
Máximo
107.45
Ingresos | 3.6M 17M |
|---|---|
Ventas | 3.4M 64M |
P/B Media del Sector | 46.291 66.845 |
Rentabilidad por dividendo | 0.74 |
Margen de beneficio | 28.441 |
Empleados | 651 |
EBITDA | -2.3M 24M |
Recomendaciones | Compra Fuerte |
|---|---|
Estimación a 12 meses | +5.38% upside |
Rentabilidad por dividendo Media del Sector | 0.74% 2.25% |
|---|---|
Próximas Ganancias | 30 abr 2026 |
Fecha Próximo Dividendo | 26 mar 2026 |
Próxima Fecha de Ex Dividendo | 12 mar 2026 |
Capitalización de Mercado | 363M 2.4B |
|---|---|
Apertura anterior | 105.49 |
Cierre anterior | 106.75 |
Noticias sobre sentimiento de mercado
By Acuity
20%
80%
36 / 351 Clasificación en Healthcare
Puntuación técnica
By Trading Central
Confianza
Very Strong Bearish Evidence
LeMaitre Vascular Inc Gráfico
El rendimiento pasado no es un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
LeMaitre Vascular Inc Esperado
Precio Objetivo
By TipRanks
5.38% repunte
Estimación a 12 meses
Media 111.86 USD 5.38%
Máximo 124 USD
Mínimo 94 USD
De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para LeMaitre Vascular Inc Dist en los últimos 3 meses.
Sentimiento
By Acuity
36 / 351 Clasificación en Salud
Noticias sobre sentimiento de mercado
Coyuntura alcista notoria
Volatilidad
Por debajo de la media
Volumen de Noticias (RCV)
Por debajo de la media
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de LeMaitre Vascular Inc
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
Live chat